Fate Therapeutics, Inc.

Total Awards:

Award Value:

$15,934,448

Institution type:

For profit

Short Name:

Fate Therapeutics

Awards to the Institution

Program Type	Investigator	Grant Title	Award Value
Therapeutic Translational Research Projects	Martin Hosking	Development of an off-the-shelf iPSC derived CAR T cell therapy for the treatment of solid tumors	$4,000,000
Clinical Trial Stage Projects	Bob Valamehr	A Phase 1 Study of FT819 in Participants with Moderate to Severe Active Systemic Lupus Erythematosus	$7,934,448
Late Stage Preclinical Projects	Bob Valamehr	IND enabling development of FT516: A Natural Killer Cell Immunotherapy for Cancer Derived from a Human Inducible Pluripotent Stem Cell	$4,000,000
			Total: $15,934,448.00